122 Avoiding Marketing Risk and Remaining Compliant with Asa Waldstein of Supplement Advisory Group
tobebluntpod.substack.com
“Go through all old social media posts and make sure there's not any high risk word lurking. This includes infographics, and hashtags, because the FDA and FTC go back several years on company social media posts.” - Asa Waldstein Welcome back to the To Be Blunt podcast! In this episode, Shayda Torabi welcomes Asa Waldstein. Asa shares about his “Warning Letter Wednesday” emails, where he breaks down the FDA warning letters. He also talks about what an FDA warning letter might be and how it plays a major role in regulating CBD products right now as hemp is federally legal.
122 Avoiding Marketing Risk and Remaining Compliant with Asa Waldstein of Supplement Advisory Group
122 Avoiding Marketing Risk and Remaining…
122 Avoiding Marketing Risk and Remaining Compliant with Asa Waldstein of Supplement Advisory Group
“Go through all old social media posts and make sure there's not any high risk word lurking. This includes infographics, and hashtags, because the FDA and FTC go back several years on company social media posts.” - Asa Waldstein Welcome back to the To Be Blunt podcast! In this episode, Shayda Torabi welcomes Asa Waldstein. Asa shares about his “Warning Letter Wednesday” emails, where he breaks down the FDA warning letters. He also talks about what an FDA warning letter might be and how it plays a major role in regulating CBD products right now as hemp is federally legal.